Increased Ca2+ buffering function of sarcoplasmic reticulum in small mesenteric arteries from spontaneously hypertensive rats

Hypertens Res. 2002 Mar;25(2):231-9. doi: 10.1291/hypres.25.231.

Abstract

We compared the Ca2+ buffering function of the superficial sarcoplasmic reticulum (SR) during rest and during contraction in endothelium-denuded strips of small mesenteric arteries from 13-week-old spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). The addition of caffeine (1-20 mM) caused a transient contraction in both strains, and the contraction was significantly larger in SHR. When the SR Ca2+ buffering function was eliminated by cyclopiazonic acid (CPA; 10 microM) or thapsigargin (100 nM), both of which inhibit SR Ca2+-ATPase, or by ryanodine (10 microM), which depletes the SR Ca2+, there was a larger contraction in SHR than in WKY, suggesting that the Ca2+ buffering function of the SR during rest is more important in SHR than in WKY. Judging from the augmenting effects of these three agents on the contractile responses to Bay k 8644 (1-300 nM), an agonist of L-type Ca2+ channels, or norepinephrine (10(-9)-10(-4) M), an alpha-adrenoceptor agonist, the effects were significantly greater in SHR than in WKY. We conclude that 1) the Ca2+ influx during rest and during stimulation with Bay k 8644 or norepinephrine is strongly buffered by Ca2+ uptake into the superficial SR in the small mesenteric arteries from SHR and WKY; and 2) these Ca2+ buffering functions are increased in SHR because of the larger capacity of SR for Ca2+ storage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Buffers
  • Calcium / metabolism*
  • Calcium Channel Agonists / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Hypertension / metabolism*
  • Hypertension / physiopathology
  • In Vitro Techniques
  • Indoles / pharmacology
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / metabolism*
  • Norepinephrine / pharmacology
  • Rats
  • Rats, Inbred SHR / metabolism*
  • Rats, Inbred WKY
  • Ryanodine / pharmacology
  • Sarcoplasmic Reticulum / metabolism*
  • Thapsigargin / pharmacology
  • Vasoconstriction / drug effects

Substances

  • Adrenergic alpha-Agonists
  • Buffers
  • Calcium Channel Agonists
  • Enzyme Inhibitors
  • Indoles
  • Ryanodine
  • Thapsigargin
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Calcium
  • Norepinephrine
  • cyclopiazonic acid